Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / U.S. PHARMA ETF
-
Total 13F shares
-
598,618
-
Share change
-
-450,603
-
Total reported value
-
$95,848,471
-
Put/Call ratio
-
177%
-
Price per share
-
$160.11
-
Number of holders
-
90
-
Value change
-
-$71,199,280
-
Number of buys
-
35
-
Number of sells
-
29
Institutional Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q4 2019
As of 31 Dec 2019,
ISHARES TR - U.S. PHARMA ETF (IHE) was held by
90 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
598,618 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, MORGAN STANLEY, ROYAL BANK OF CANADA, Fisher Asset Management, LLC, BROWN ADVISORY INC, CITADEL ADVISORS LLC, BANK OF AMERICA CORP /DE/, MURPHY CAPITAL MANAGEMENT INC, COMMONWEALTH EQUITY SERVICES, LLC, and WELLS FARGO & COMPANY/MN.
This page lists
91
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.